Olema Pharmaceuticals | 8-K: Current report
Olema Pharmaceuticals | 8-K: Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
Olema Pharmaceuticals | DEFA14A: Others
Olema Pharmaceuticals | DEF 14A: Definitive information statements
Olema Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Olema Pharmaceuticals | 8-K: Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
Olema Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Olema Pharmaceuticals | 8-K: Current report
Olema Pharmaceuticals | 8-K: Current report
Olema Pharmaceuticals | 8-K: Current report
Olema Pharmaceuticals | 8-K: Current report
Olema Pharmaceuticals | 8-K: Current report
Olema Pharmaceuticals | 8-K: Olema Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Olema Pharmaceuticals | 8-K: Current report
Olema Pharmaceuticals | 8-K/A: Current report (Amendment)
Olema Pharmaceuticals | 8-K: Current report
Olema Pharmaceuticals | 8-K: Current report
Olema Pharmaceuticals | 8-K: Current report
Olema Pharmaceuticals | 8-K: Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Olema Pharmaceuticals | 8-K: Current report
No Data